Infinity Pharmaceuticals Buy or Sell Recommendation

Macroaxis provides Infinity Pharmaceuticals Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Infinity Pharmaceuticals positions. The advice algorithm takes into account all of Infinity Pharmaceuticals Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Infinity Pharmaceuticals buy-and-hold prospective. Please also check Infinity Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon

  

Risk Tolerance

  
Symbol
Execute Advice
Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.1  0.18  7.89%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Infinity Pharmaceuticals Inc is 'Strong Sell'.
For the selected time horizon Infinity Pharmaceuticals Inc has a mean deviation of 14.35, semi deviation of 9.44, standard deviation of 28.1, variance of 789.81, downside variance of 136.9 and semi variance of 89.04
We provide buy, hold, or sell suggestion to complement the regular expert consensus on Infinity Pharmaceuticals. Our dynamic recommendation engine utilizes multi - dimensional algorithm to analyze the organization potential to grow using all technical and fundamental data available at the time. To make sure Infinity Pharmaceuticals Inc is not overpriced, please check out all Infinity Pharmaceuticals fundamentals including its Debt to Equity, Beta and the relationship between EBITDA and Short Ratio . Please also validate Infinity Pharmaceuticals Price to Earning to confirm your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Returns Distribution Density

Mean Return5.54Value At Risk-22.2222
Potential Upside16.6667Standard Deviation28.1036
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Acadian Asset Management LlcCommon Shares37 K49 K
American Financial Network Advisory Services LlcCommon Shares1280.0
Bvf IncCommon Shares7.9 M12.3 M
Wellington Management Group LlpCommon Shares4.7 M7.4 M
Vanguard Group IncCommon Shares4.6 M7.3 M
Orbimed Advisors LlcCommon Shares3.3 M5.1 M
Pinnacle Associates LtdCommon Shares1.2 M2 M

Infinity Pharmaceuticals Greeks

α
Alpha over DOW
= 2.86 
βBeta against DOW= 19.05 
σ
Overall volatility
= 28.1 
 IrInformation ratio = 0.19 

Infinity Pharmaceuticals Volatility Alert

Infinity Pharmaceuticals Inc is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to make sure related market timing strategies are aligned with all the expectations about Infinity Pharmaceuticals implied risk.
    
 Better Than Average     
    
 Worse Than Average Compare Infinity Pharmaceuticals to competition
FundamentalsInfinity PharmaceuticalsPeer Average
Return On Equity(78.61) % (15.17) %
Return On Asset(26.58) % (15.64) %
Current Valuation(8.41 M)152.14 B
Shares Outstanding50.69 M1.43 B
Shares Owned by Insiders2.57 % 6.91 %
Shares Owned by Institutions72.41 % 18.37 %
Number of Shares Shorted1.39 M3.24 M
Price to Earning(2.12) times40.69 times
Price to Book2.53 times14.44 times
Gross Profit18.72 M21.75 B
EBITDA(55.73 M)1.41 B
Net Income(69.61 M)517.71 M
Cash and Equivalents66.2 M3.89 B
Cash per Share1.31 times5.17 times
Debt to Equity0.23 % 0.72 %
Current Ratio6.29 times3.3 times
Book Value Per Share1.17 times13.64 times
Cash Flow from Operations(82.94 M)1.25 B
Short Ratio4 times2.09 times
Earnings Per Share(1.39) times2.3 times
Price to Earnings To Growth(0.05) times1.22 times
Number of Employees4810.67 K
Beta2.140.34
Market Capitalization149.53 M29.78 B
Total Asset288.82 M126.86 B
Retained Earnings(595.59 M)38.24 B
Working Capital184.64 M3.58 B
Current Asset254.7 M36.8 B
Current Liabilities70.06 M33.34 B
Z Score-2.8708.73
SellBuy
Strong Sell

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
   Purchase by Bvf Partners L P of 63042 shares of Infinity Pharmaceuticals [view details]
Risk Adjusted Performance0.0611
Market Risk Adjusted Performance0.3002
Mean Deviation14.35
Semi Deviation9.44
Downside Deviation11.7
Coefficient Of Variation507.33
Standard Deviation28.1
Variance789.81
Information Ratio0.1918
Jensen Alpha2.86
Total Risk Alpha(9.63)
Sortino Ratio0.4606
Treynor Ratio0.2902
Maximum Drawdown144.81
Value At Risk(22.22)
Potential Upside16.67
Downside Variance136.9
Semi Variance89.04
Expected Short fall(22.66)
Skewness3.66
Kurtosis15.71

Current Valuation

Infinity Pharmaceuticals Current Valuation Analysis
Infinity Pharmaceuticals Inc is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceutical Products industry is currently estimated at about 863 Million. Infinity Pharmaceuticals has negative current valuation of (8.41 Million) contributing nothing to the industry.